These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17023816

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Psoriatic lesions induced by antitumour necrosis factor-alpha treatment: two cases.
    Dereure O, Guillot B, Jorgensen C, Cohen JD, Combes B, Guilhou JJ.
    Br J Dermatol; 2004 Aug; 151(2):506-7. PubMed ID: 15327565
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?
    Michaëlsson G, Kajermo U, Michaëlsson A, Hagforsen E.
    Br J Dermatol; 2005 Dec; 153(6):1243-4. PubMed ID: 16307676
    [No Abstract] [Full Text] [Related]

  • 9. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
    Roos JC, Chilvers ER, Ostor AJ.
    J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
    [No Abstract] [Full Text] [Related]

  • 10. New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.
    Kary S, Worm M, Audring H, Huscher D, Renelt M, Sörensen H, Ständer E, Maass U, Lee H, Sterry W, Burmester GR.
    Ann Rheum Dis; 2006 Mar; 65(3):405-7. PubMed ID: 16150791
    [Abstract] [Full Text] [Related]

  • 11. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
    Papadavid E, Gazi S, Dalamaga M, Stavrianeas N, Ntelis V.
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pustular psoriasis induced by infliximab.
    Martínez-Morán C, Sanz-Muñoz C, Morales-Callaghan AM, Torrero V, Miranda-Romero A.
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1424-6. PubMed ID: 17958859
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis.
    Capkin E, Karkucak M, Yayli S, Aydin Çapkin A, Tosun M.
    J Clin Rheumatol; 2011 Aug; 17(5):293-4. PubMed ID: 21808187
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.